Results 11 to 20 of about 41,675 (347)

Use of Right Ventricular Assist Device Post-Left Ventricular Assist Device Placement

Hearts
Right heart failure (RHF) is a common manifestation after left ventricular assist device (LVAD) placement and is associated with a high mortality rate. Historically, RV failure requiring an RVAD at the time of LVAD implantation has been associated with ...
Shannon Parness, Tori E. Hester, Harish Pandyaram, Panagiotis Tasoudis, Aurelie E. Merlo   +4 more
doaj   +2 more sources

Temporary Right-Ventricular Assist Devices: A Systematic Review [PDF]

Journal of Clinical Medicine, 2022
Acute right-sided heart failure (RHF) is a complex clinical syndrome, with a wide range of clinical presentations, associated with increased mortality and morbidity, but about which there is a scarcity of evidence-based literature. A temporary right-ventricular assist device (t-RVAD) is a potential treatment option for selected patients with severe ...
Mahmoud Abdelshafy, Kadir Caliskan, Goksel Guven, Ahmed Elkoumy, Hagar Elsherbini, Hesham Elzomor, Erhan Tenekecioglu, Sakir Akin, Osama Soliman   +8 more
openaire   +5 more sources

Right Ventricular Failure Following Left Ventricular Assist Device Implantation

World Journal of Cardiovascular Surgery, 2020
Left ventricular assist device (LVAD) is being used increasingly in recent years for end stage heart failure as a bridge to transplant (BTT) and also as a destination therapy (DT). Patients with end stage heart failure have some degree of elevated pulmonary capillary wedge pressure, causing right ventricular hypertrophy which in due course leads to
Niraghatam Harshavardhan, Amitabh Satsangi   +1 more
openalex   +3 more sources

Transesophageal Echocardiography-Guided ProtekDuo Percutaneous Temporary Right Ventricular Assist Device Cannulation Technique [PDF]

Annals of Cardiac Anaesthesia
Bronson Crawford, Shiv Rawal, Mindaugas Rackauskas, Marc O. Maybauer   +3 more
doaj   +2 more sources

Right and left ventricular assist devices are an option for bridge to heart transplantCentral MessagePerspective

JTCVS Open, 2022
Background: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized.
Yaron D. Barac, MD, PhD, Ronen Toledano, MD, Oliver K. Jawitz, MD, Jacob N. Schroder, MD, Mani A. Daneshmand, MD, Chetan B. Patel, MD, Dan Aravot, MD, Carmelo A. Milano, MD   +7 more
doaj   +1 more source

Supporting the “forgotten” ventricle: The evolution of percutaneous RVADs

Frontiers in Cardiovascular Medicine, 2023
Right heart failure (RHF) can occur as the result of an acute or chronic disease process and is a challenging clinical condition for surgeons and interventionalists to treat.
Les James, Deane E. Smith
doaj   +1 more source

Case report: Facilitating right heart recovery after durable LVAD implantation through repair of atrioventricular valves and RVAD implantation using tunneled Dacron grafts

Frontiers in Cardiovascular Medicine, 2023
Right ventricular assist device (RVAD) weaning is often an important goal for durable left ventricular assist device support. This may be facilitated by mitral and tricuspid repair as well as by minimizing the trauma of RVAD decannulation by using Dacron
K. Candis Jones-Ungerleider, Syed Sikandar Raza, Paul C. Tang, Paul C. Tang   +3 more
doaj   +1 more source

Experience with percutaneous right ventricular support in the early post-left ventricular assist device implantation period (clinical case report and literature reviews)

Вестник трансплантологии и искусственных органов, 2023
Implantable left ventricular assist device (LVAD) is a state-of-the-art treatment for adults and children with end-stage heart failure. The early and late period after LVAD implantation can be severely complicated.
V. N. Poptsov, E. A. Spirina, D. V. Ryabtsev, A. K. Solodovnikova, A. S. Epremian   +4 more
doaj   +1 more source

Percutaneous left ventricular assist devices in refractory cardiac arrest: The role of chest compressions

Resuscitation Plus, 2023
Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula, Brendan M. McCracken, Takahiro Nakashima, Nicholas L. Greer, Traci A. Cramer, Nadia R. Sutton, Kevin R. Ward, Robert W. Neumar, Mohamad Hakam Tiba, Cindy H. Hsu   +9 more
doaj   +1 more source

Biventricular assist devices and total artificial heart: Strategies and outcomes

Frontiers in Cardiovascular Medicine, 2023
In contrast to the advanced development of the left ventricular assist device (LVAD) therapy for advanced heart failure, the mechanical circulatory support (MCS) with biventricular assist device (BVAD) and total artificial heart (TAH) options remain ...
Taiyo Kuroda, Chihiro Miyagi, Kiyotaka Fukamachi, Kiyotaka Fukamachi, Jamshid H. Karimov, Jamshid H. Karimov   +5 more
doaj   +1 more source